Quarterly Report

CORCEPT THERAPEUTICS INC Filed 2026-07-29 Acc 0001628280-26-050613

Documents 1

2026-11-03 10-Q Quarterly Report
2026-08-03 144 Sale of Securities
2026-08-03 4 Chief Financial Officer sold 80,000 shares at an average $114.71 ($9,177,109)
2026-07-30 144 Sale of Securities
2026-07-29 10-Q Quarterly Report
2026-07-29 8-K Results of operations · Regulation FD disclosure
2026-04-30 10-Q Quarterly Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading cort-20260630.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…